Association of hypoalbuminemia with severe anemia in patients with diabetic nephrosclerosis

Renal Failure

Volumn 34, Issue 2, 2012, Pages 189-193

  Sasatomi, Yoshie ^a   Ito, Kenji ^a   Abe, Yasuhiro ^a   Miyake, Katsuhisa ^a   Ogahara, Satoru ^a   Nakashima, Hitoshi ^a   Saito, Takao ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Anemia; Diabetic nephrosclerosis; Hypoalbuminemia; Malnutritioninflammationatherosclerosis syndrome

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; IRON; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IRON BLOOD LEVEL; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANEMIA; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOALBUMINEMIA; MALE; MIDDLE AGED; NEPHROSCLEROSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84856647837     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.646885     Document Type: Article

References (34)

1. The statistic analyzed commission of Japan Society for Dialysis Therapy: An overview of dialysis treatment in Japan (as of December 31, 2008): 12.
2. Sasatomi Y, Kaneoka H, Abe Y, et al. Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus. Clin Exp Nephrol. 2009;13: 473-479.
3. Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426-430. (Pubitemid 27156736)
4. Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study. Kidney Int. 2003;63:1499-1507. (Pubitemid 36350016)
5. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69-75. (Pubitemid 28304880)
6. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001;60:277-283. (Pubitemid 32587565)
7. Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62:202-228.
8. Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346: 1145-1151. (Pubitemid 34984606)
9. ShestakovaMV, Chugunova LA, Shamkhalova MSh, Dirochka IuA, Dedov II. Diabetic nephropathy: Risk factors of rapid progression of renal failure. Ter Arkh. 1999;71:45-49.
10. Ravanan R, Spiro JR, Mathieson PW, et al. Impact of diabetes on hemoglobin levels in renal disease. Diabetologia 2007;50: 26-31. (Pubitemid 46035848)
11. Li Vecchi M, Fuiano G, Francesco M, et al. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency. Nephron Clin Pract. 2007;105:c62-c67. (Pubitemid 46143908)
12. Thomas MC, Tsalamandris C, Macisaac R, Jerums G. Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia. Diabet Med. 2006;23:502-509.
13. Katavetin P, Miyata T, Inagi R, et al. High glucose blunts VEGF response to hypoxia via the oxidative stress-regulated HIF-HRE pathway. J Am Soc Nephrol. 2006;17:1405-1413.
14. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diab Care. 2001;24:495-499. (Pubitemid 32198419)
15. Bayes B, Serra A, Junca J, Lauzurica R. Successful treatment of anemia of nephrotic syndrome with recombinant human erythropoietin. Nephrol Dial Transplant. 1998;13: 1894-1895. (Pubitemid 28306847)
16. Lorber D, Reddan D. Clinical characteristics of chronic kidney disease patients with and without diabetes: A subanalysis of the PAERI study. Clin Nephrol. 2006;66:11-16. (Pubitemid 44043727)
17. Ishimura E, Nishizawa Y, Okuno S, et al. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol. 1998;11:83-86. (Pubitemid 28206794)
18. Furuta T, Saito T, Ootaka T, et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis. 1993;21: 480-485. (Pubitemid 23160508)
19. Sasatomi Y, Sato H, Chiba Y, et al. Prognostic factors for renal amyloidosis: A clinicopathological study using cluster analysis. Int Med. 2007;46:213-219. (Pubitemid 46403662)
20. Hishida A, Yokoyama H, Tomino Y, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. Epub 2009;53:982-992.
21. Kazmi WH, Kausz AT, Khan S, et al.. Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803-812.
22. Vlagopoulos PT, Tighiouart H, Weiner DE, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: The impact of chronic kidney disease. J Am Soc Nephrol. 2005;16:3403-3410. (Pubitemid 46179344)
23. Silverberg DS, Wexler D, Blum M, Wollman Y, Iaina A. The cardio-renal anemia syndrome: Does it exist? Nephrol Dial Transplant. 2003;18(Suppl. 8):S7-S12.
24. Ritz E, Laville M, Bilous RW, et al. Anemia correction in diabetes study investigators. Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the Anemia Correction in Diabetes (ACORD) Study. Am J Kidney Dis. 2007;49:194-207. (Pubitemid 46178405)
25. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085-2098. (Pubitemid 44749317)
26. Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019-2032.
27. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997;77:176-185. (Pubitemid 27440408)
28. Lee H, Manns B, Taub K, et al.. Cost analysis of ongoing care of patients with end stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40: 611-622. (Pubitemid 34971291)
29. Nakao T, Kanazawa Y, Matsumoto H, Okada T, Nagaoka Y. Effective dietary protein restriction in the treatment of diabetic nephropathy. Nephrol Front. 2005;4:166-167.
30. Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: A meta-analysis of randomized controlled trial. Am J Clin Nut. 2008;88:660-666.
31. American Diabetes Association. Standards of medical care in diabetes-2009. Diab Care. 2009;32(Suppl. 1):s13-s61.
32. Nakao T, Okada T. Meaning and problems in low-protein diet for renal failure. Jpn J Soc Int Med. 2006;95:368-373.
33. Stenvinkel P, Heimbürger O,Wang T, Elinder C-G, Bergström J, Lindholm B. A syndrome of malnutrition, inflammation and atherosclerosis(MIA) is associated with elevated serum hyaluronan and increased mortality in chronic renal failure (CRF). J Am Soc Nephrol. 1999;10:182A.
34. Kato A. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome. Future Cardiol. 2010;6:769-771.